Abstract:Fibroblast growth factor 2 (FGF-2) is known to play a pivotal role in bone remodeling and osteogenesis. Dexamethasone is a potent modulator of osteogenic differentiation and can increase the bone formation capacity of cementoblasts. However, the combined effects of FGF-2 and dexamethasone on cementoblasts and the way they regulate the activities of cementoblasts have not been fully understood. The aim of this study was to clarify and investigate the effects of the combination of FGF-2 and dexamethasone on growth and differentiation in human cementoblasts and to determine the underlying mechanism. A series of experiments including MTT, alkaline phosphatase (ALP) activity, alizarin red staining, RT-PCR, and Western blot were carried out to evaluate the proliferation and differentiation of cementoblasts. In addition, the changes of Wnt signaling pathway molecules were checked to analyze the possible mechanism. Compared to the treatment of cementoblasts with either FGF 2 or dexamethasone alone, the combination of FGF-2 and dexamethasone synergistically increased cell proliferation, ALP activity, nodule formation, and expression of differentiation markers. In addition, FGF 2 and dexamethasone enhanced expression of Wnt3a, Runx2, β-catenin, and p-GSK-3β, all of which were inhibited by DKK1. Taken together, FGF-2 and dexamethasone act synergistically, enhancing each other's ability to stimulate cementoblast growth and differentiation via Wnt signaling pathways. These results support the therapeutic potential of a combination strategy for facilitating cementogenesis and aiding periodontal regeneration.

The expression of BMP-2 in cementifying fibroma of the jaw and its clinical significance

Expression of BMP-2mRNA in Cementifying Fibroma of the Jaw

The expression of BMP-2 mRNA in ameloblastoma of the jaw bone

Expression of BMP-2 in Osteosarcoma of the Jaw Bone and Its Clinical Significance

Research on gene amplification of BMP-2 in jawbone tumors by RT-PCR

The Expression of BMP-2mRNA in Osteosarcoma of the Jaw and Its Relationship to Lymph Node Metastasis

Expression of BMP-2 Gene in Odontogenic Tumors

Research on gene expression of BMP-2 in pleomorphic adenoma of parotid gland

Construction of a Eukaryotic Expression Vector Pegfp-C1-bmp-2 and Its Effect on Cell Migration

Cell Biocompatibility of Hydroxyapatite/Silk Fibroin Composite Scaffolds Carrying Bone Morphogenetic Protein

Clinical and Pathological Study of Benign Cementoblastoma (A Report of 12 Cases)

[Expression of Receptor Activator of NF-kappa B Ligand and Osteoprotegerin Protein in the Giant Cell Lesions of Jaw].

Progresses in the Study of Fibrous Dysplasia of the Jaw Bone

Cemento-Ossifying Fibroma Extensive In The Mandible - Case Report.

[Expression of Macrophage Inflammatory Protein-1Alpha, a Disintegrin-Like and Metalloproteinase 8 and 12, and CD68 Protein in Giant Cell Lesions of Jaw and Giant Cell Tumors of Long Bone].

Combined effects of fibroblast growth factor 2 and dexamethasone on differentiation of human cementoblasts

[Expression of a Disintegrin-Like and Metalloproteinase Protein 8 and 12 in the Giant Cell Lesions of Jaw].

Acellular Extrinsic Fiber Cementum Is Invariably Present in the Superficial Layer of Apical Cementum in Mouse Molar

Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas.

Cemento-Ossifying Fibroma: Report Of A Case Diagnosed In Routine Exams.

Synergistic effects of fibroblast growth factor-2 and bone morphogenetic protein-2 on bone induction